Baseline levels of miR-223-3p correlate with the effectiveness of electroconvulsive therapy in patients with major depression.
Journal
Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664
Informations de publication
Date de publication:
13 09 2023
13 09 2023
Historique:
received:
01
09
2022
accepted:
07
08
2023
revised:
02
08
2023
medline:
14
9
2023
pubmed:
13
9
2023
entrez:
12
9
2023
Statut:
epublish
Résumé
There is a strong medical need to develop suitable biomarkers to improve the diagnosis and treatment of depression, particularly in predicting response to certain therapeutic approaches such as electroconvulsive therapy (ECT). MicroRNAs are small non-coding RNAs that have the ability to influence the transcriptome as well as proteostasis at the systems level. Here, we investigate the role of circulating microRNAs in depression and response prediction towards ECT. Of the 64 patients with treatment-resistant major depression (MDD) who received ECT treatment, 62.5% showed a response, defined as a reduction of ≥50% in the MADRS total score from baseline. We performed smallRNA sequencing in blood samples that were taken before the first ECT, after the first and the last ECT. The microRNAome was compared between responders and non-responders. Co-expression network analysis identified three significant microRNA modules with reverse correlation between ECT- responders and non-responders, that were amongst other biological processes linked to inflammation. A candidate microRNA, namely miR-223-3p was down-regulated in ECT responders when compared to non-responders at baseline. In line with data suggesting a role of miR-223-3p in inflammatory processes we observed higher expression levels of proinflammatory factors Il-6, Il-1b, Nlrp3 and Tnf-α in ECT responders at baseline when compared to non-responders. ROC analysis of confirmed the diagnostic power of miR-223-3p demarcating ECT-responders from non-responder subjects (AUC = 0.76, p = 0.0031). Our data suggest that miR-223-3p expression and related cytokine levels could serve as predictors of response to ECT in individuals with treatment-resistant depressive disorders.
Identifiants
pubmed: 37699900
doi: 10.1038/s41398-023-02582-4
pii: 10.1038/s41398-023-02582-4
pmc: PMC10497550
doi:
Substances chimiques
MicroRNAs
0
MIRN223 microRNA, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
294Informations de copyright
© 2023. Springer Nature Limited.
Références
Transl Psychiatry. 2017 Feb 7;7(2):e1023
pubmed: 28170003
EMBO Mol Med. 2021 Nov 8;13(11):e13659
pubmed: 34633146
Neuropsychobiology. 2020;79(3):222-232
pubmed: 32114575
Acta Psychiatr Scand. 2017 Jan;135(1):87-92
pubmed: 27858966
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Mol Diagn Ther. 2020 Jun;24(3):279-298
pubmed: 32304043
JAMA Psychiatry. 2013 Jan;70(1):31-41
pubmed: 22945416
Neuropsychopharmacology. 2021 Jun;46(7):1324-1332
pubmed: 33833401
Front Neurosci. 2019 Feb 11;13:98
pubmed: 30804748
Biol Psychiatry. 2017 Dec 15;82(12):914-923
pubmed: 28629541
Int J Biol Sci. 2021 Jun 4;17(9):2308-2322
pubmed: 34239357
Genome Biol. 2009;10(3):R25
pubmed: 19261174
Alzheimers Dement (Amst). 2020 Mar 05;12(1):e12001
pubmed: 32211497
Acta Psychiatr Scand. 2016 Jul;134(1):40-7
pubmed: 27028967
Neuropharmacology. 2022 May 1;208:108984
pubmed: 35131296
Mol Oncol. 2017 Dec;11(12):1673-1686
pubmed: 29024380
Transl Psychiatry. 2016 Aug 02;6(8):e862
pubmed: 27483380
Nat Rev Dis Primers. 2016 Sep 15;2:16065
pubmed: 27629598
J Clin Psychiatry. 2020 Dec 15;82(1):
pubmed: 33326710
Bioinformatics. 2015 Sep 15;31(18):3075-7
pubmed: 25964630
Neuron. 2020 Jul 22;107(2):234-256
pubmed: 32553197
Cells. 2020 Jul 04;9(7):
pubmed: 32635578
Biol Psychiatry. 2022 Aug 1;92(3):193-203
pubmed: 35120710
Expert Opin Pharmacother. 2010 Apr;11(5):709-22
pubmed: 20151847
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Neuroimmunol. 2015 Aug 15;285:143-6
pubmed: 26198931
J Neuroinflammation. 2021 Feb 16;18(1):45
pubmed: 33593388
Front Cell Neurosci. 2019 Aug 07;13:363
pubmed: 31440144
Genes Chromosomes Cancer. 2018 Apr;57(4):192-202
pubmed: 29226599
Brain Behav Immun. 2017 Aug;64:367-383
pubmed: 28263786
Stereotact Funct Neurosurg. 2021;99(3):256-266
pubmed: 33152730
Nat Commun. 2019 Sep 12;10(1):4136
pubmed: 31515491
J Immunol. 2012 Oct 15;189(8):4175-81
pubmed: 22984082
Transl Psychiatry. 2021 Oct 8;11(1):514
pubmed: 34625536
Front Immunol. 2019 Jul 19;10:1696
pubmed: 31379879
Eur Arch Psychiatry Clin Neurosci. 2021 Apr;271(3):475-485
pubmed: 32361811
Patient Prefer Adherence. 2012;6:369-88
pubmed: 22654508
J Affect Disord. 2018 Nov;240:146-154
pubmed: 30071418
Brain Behav Immun. 2013 Jul;31:105-14
pubmed: 23261775
J ECT. 2003 Dec;19(4):183-8
pubmed: 14657769
Neuropsychiatry (London). 2014 Feb;4(1):33-54
pubmed: 24778709
Cell Res. 2017 Jul;27(7):882-897
pubmed: 28429770
Mol Psychiatry. 2012 Apr;17(4):359-76
pubmed: 22182940
Int J Environ Res Public Health. 2020 Apr 14;17(8):
pubmed: 32295141
Biol Psychiatry. 2000 Jun 15;47(12):1043-9
pubmed: 10862803
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Biol Psychiatry. 2022 Mar 15;91(6):540-549
pubmed: 34274106
Psychiatry Res. 2021 Mar;297:113735
pubmed: 33497973
J Clin Psychiatry. 2005;66 Suppl 8:5-12
pubmed: 16336031
Front Neurosci. 2017 May 22;11:278
pubmed: 28588440
Brain Behav Immun. 2020 Oct;89:59-66
pubmed: 32479994
Nat Rev Mol Cell Biol. 2019 May;20(5):321
pubmed: 30728477
Biol Psychiatry. 2008 Sep 15;64(6):484-90
pubmed: 18514163
Biochem Pharmacol. 2014 Oct 15;91(4):522-33
pubmed: 25150213
Braz J Psychiatry. 2020 Aug;42(4):403-419
pubmed: 32187319
Eur J Neurosci. 2021 Jun;53(12):3879-3888
pubmed: 32673433
J Affect Disord. 2010 Dec;127(1-3):332-6
pubmed: 20579744
Elife. 2019 Oct 23;8:
pubmed: 31644424
PLoS One. 2013 Jul 26;8(7):e69869
pubmed: 23922833
Nat Commun. 2019 Sep 2;10(1):3924
pubmed: 31477731
Neurotherapeutics. 2021 Oct;18(4):2664-2681
pubmed: 34664178
Brain Behav. 2020 Jul;10(7):e01654
pubmed: 32406210
Sci Transl Med. 2017 Sep 20;9(408):
pubmed: 28931657
Nat Rev Immunol. 2019 Aug;19(8):477-489
pubmed: 31036962
J Affect Disord. 2021 May 1;286:80-86
pubmed: 33714174
Brain Stimul. 2018 Jan - Feb;11(1):29-51
pubmed: 29111078
Genesis. 2015 Jul;53(7):395-416
pubmed: 26138457
Transl Psychiatry. 2016 Jun 07;6(6):e832
pubmed: 27271858
Front Immunol. 2021 Dec 10;12:781815
pubmed: 34956210
Nat Biotechnol. 2014 Sep;32(9):896-902
pubmed: 25150836
Acta Psychiatr Scand. 2017 Dec;136(6):594-606
pubmed: 28975998
Adv Exp Med Biol. 2019;1118:175-190
pubmed: 30747423
BMC Psychiatry. 2015 Aug 05;15:191
pubmed: 26242794
Br J Psychiatry. 2018 Feb;212(2):71-80
pubmed: 29436330
Brain Behav Immun. 2014 Feb;36:111-7
pubmed: 24513871
Cardiovasc Pathol. 2015 Jul-Aug;24(4):199-206
pubmed: 25958013
Gene Ther. 2011 Dec;18(12):1104-10
pubmed: 21525952